Primary Ciliary Dyskinesia Market is driven by Gene Therapy...

σε πρόσθεσε στο Health

2025-04-29 12:18:46 -

Primary Ciliary Dyskinesia Market is driven by Gene Therapy Advancements

The Primary Ciliary Dyskinesia (PCD) Market encompasses diagnostic assays, pharmacological interventions, and innovative gene-based treatments designed to address the structural and functional defects of motile cilia in respiratory epithelium. Products include genetic testing panels, high-resolution microscopy diagnostics, inhaled mucolytics, anti-inflammatory agents, and emerging gene-editing...

0 Σχόλια 0 Μοιράστηκε 425 Views 0 Προεπισκόπηση